Effect of TNF-α on Molecules Related to the Insulin Action in Endometrial Cells Exposed to Hyperandrogenic and Hyperinsulinic Conditions Characteristics of Polycystic Ovary Syndrome
- PMID: 28946816
- DOI: 10.1177/1933719117732157
Effect of TNF-α on Molecules Related to the Insulin Action in Endometrial Cells Exposed to Hyperandrogenic and Hyperinsulinic Conditions Characteristics of Polycystic Ovary Syndrome
Abstract
Polycystic ovary syndrome (PCOS) affects not only ovarian functions but is also able to affect endometrium metabolism. Around 80% of women with PCOS are obese. High tumor necrosis factor (TNF)-α production and low adiponectin levels are characteristics of obesity. Interestingly, endometrium from obese women with PCOS presents an insulin-resistance condition, high TNF-α levels, and low adiponectin levels. However, TNF-α effect on molecules associated with insulin action in endometrial cells remains unclear. Therefore, the objective of this work was to evaluate TNF-α effect on expression of molecules associated with adiponectin (insulin sensitizing) and TNF-α signaling pathways and on Glucose Transporter type 4 (GLUT-4) levels in human endometrial cells under the characteristic conditions of hyperandrogenic/hyperinsulinic (HA/HI) PCOS. Two human endometrial stromal cell lines (T-HESC/St-T1b) under HA/HI conditions were used to assay the effect of high TNF-α concentration (100 ng/mL) on adiponectin, AdipoR1-AdipoR2 receptors, Adaptor protein phosphotyrosine interacting with PH domain and leucine zipper 1 (APPL1), Phospho-AMP-activated protein kinase T172 (p-AMPKT172), GLUT-4, Tumor necrosis factor receptor 1 (TNFR1)-Tumor necrosis factor receptor 2 (TNFR2) receptors protein levels, and nuclear factor κB (NFκB) nuclear content, by Western blot or immunocytochemistry. The NFκB participation in TNF-α effect on adiponectin expression was assayed using an NFκB inhibitor (pyrrolidine dithiocarbamate). The TNF-α increases the expression of molecules associated with its own signaling pathway ( P < .05) and decreases the protein levels of adiponectin and its associated molecules ( P < .05). Moreover, TNF-α increases NFκB nuclear content ( P < .001), whereas with NFκB inhibition the decrease in adiponectin content induced by TNF-α was not observed. GLUT-4 levels were lower with TNF-α treatment ( P < .01). Thus, in human endometrial stromal cells, high TNF-α levels negatively affect the insulin action through decreased adiponectin signaling and GLUT-4 protein. This could explain the failures observed in endometrial function of obese women with PCOS.
Keywords: GLUT-4; TNF-α; adiponectin; endometrial cells; insulin.
Similar articles
-
Proinflammatory environment and role of TNF-α in endometrial function of obese women having polycystic ovarian syndrome.Int J Obes (Lond). 2016 Nov;40(11):1715-1722. doi: 10.1038/ijo.2016.154. Epub 2016 Aug 29. Int J Obes (Lond). 2016. PMID: 27569685
-
Effect of TNF-alpha on endometrial glucose transporter-4 expression in patients with polycystic ovary syndrome through nuclear factor-kappa B signaling pathway activation.J Physiol Pharmacol. 2021 Dec;72(6). doi: 10.26402/jpp.2021.6.13. Epub 2022 Apr 24. J Physiol Pharmacol. 2021. PMID: 35485360
-
Endometria from Obese PCOS Women with Hyperinsulinemia Exhibit Altered Adiponectin Signaling.Horm Metab Res. 2015 Nov;47(12):901-9. doi: 10.1055/s-0035-1555806. Epub 2015 Jul 21. Horm Metab Res. 2015. PMID: 26197851
-
Altered Steroid Metabolism and Insulin Signaling in PCOS Endometria: Impact in Tissue Function.Curr Pharm Des. 2016;22(36):5614-5624. doi: 10.2174/1381612822666160810111528. Curr Pharm Des. 2016. PMID: 27514712 Review.
-
Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.Dan Med J. 2014 Jul;61(7):B4890. Dan Med J. 2014. PMID: 25123125 Review.
Cited by
-
Metformin Treatment Regulates the Expression of Molecules Involved in Adiponectin and Insulin Signaling Pathways in Endometria from Women with Obesity-Associated Insulin Resistance and PCOS.Int J Mol Sci. 2022 Apr 1;23(7):3922. doi: 10.3390/ijms23073922. Int J Mol Sci. 2022. PMID: 35409282 Free PMC article.
-
Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome.Front Endocrinol (Lausanne). 2023 Oct 19;14:1191759. doi: 10.3389/fendo.2023.1191759. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37929034 Free PMC article. Review.
-
The Disorders of Endometrial Receptivity in PCOS and Its Mechanisms.Reprod Sci. 2022 Sep;29(9):2465-2476. doi: 10.1007/s43032-021-00629-9. Epub 2021 May 27. Reprod Sci. 2022. PMID: 34046867 Review.
-
Hippo Signaling in the Ovary: Emerging Roles in Development, Fertility, and Disease.Endocr Rev. 2022 Nov 25;43(6):1074-1096. doi: 10.1210/endrev/bnac013. Endocr Rev. 2022. PMID: 35596657 Free PMC article. Review.
-
Polycystic ovary syndrome associated with increased adiposity interferes with serum levels of TNF-alpha and IL-6 differently from leptin and adiponectin.Arch Endocrinol Metab. 2020 Feb;64(1):4-10. doi: 10.20945/2359-3997000000197. Epub 2020 Mar 13. Arch Endocrinol Metab. 2020. PMID: 32187268 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical